Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 196 results for "lupin"

Lupin shares continue to fall; tank nearly 8% after Q4 net profit drops 49%

Lupin shares tank over 7%, mcap dips by Rs 5,003 cr in 2 days

Continuing to fall for the second straight session today on earnings disappointment, shares of drug firm Lupin today ended the day over 7 per cent lower, wiping out Rs 5,003 crore from its market valuation in two days. DNA, 5 hours ago
Lupin shares continue to fall; tank nearly 8% Business Standard, 8 hours ago

168 images for lupin

Sify, 7 hours ago
Money Control, 1 day ago
Money Control, 7 hours ago
Sify, 1 day ago
Money Control, 9 hours ago
Money Control, 12 hours ago
Money Control, 13 hours ago
Reuters, 1 day ago
Money Control, 3 days ago
Money Control, 6 days ago
Money Control

Market Live: Street sees sharp surge as Sensex rises over 300 pts, Nifty above 9450

Larsen Toubro and ICICI Bank gained the most on both indices, while Lupin, Dr Reddy’s Laboratories lost the most.
 Money Control6 hours ago Market Live: Sensex extends its gains, Nifty reclaims 9400; IT stocks gain  Money Control10 hours ago Market Live: Sensex, Nifty trade strong on expiry day; pharma continues to bleed  Money Control7 hours ago Market Live: Sensex, Nifty continue uptrend; Europe could open higher  Money Control8 hours ago

Lupin slumps to near 3-year low on weak quarterly results

Lupin Ltd falls as much as 7.7 pct to its lowest since Aug. 8, 2014. Pharma company posted a 49 pct fall in consolidated net profit for the March quarter, missing analysts' estimates. Says it expects more pricing pressure in the United States and is currently ...
 Sify7 hours ago BUZZ-India's Lupin slumps to near 3-yr low on weak qtrly results  Sify11 hours ago Major losers from the sensex pack were Tata Motors  DNA2 weeks ago
Money Control

Pharmaceuticals bleed for second consecutive day; Lupin, DRL touch 52-week lows

Both the pharma indices on Sensex and Nifty plunged to their 52-week lows, eroding a massive chunk of investors’ wealth.
 Money Control7 hours ago Lupin slips over 7%, hits fresh 52-week low; CLSA downgrades cuts target price  Money Control12 hours ago Coal India, Lupin, Aurobindo Pharma, Wockhardt, RCom hit 52-week low  Business Standard2 days ago Lupin hits fresh 32-month low  Business Standard2 weeks ago

Lupin hits 33-month low on weak Q4 results

It past two months, the stock underperformed the market by falling 24% against 3% rise in Sensex.
 Business Standard11 hours ago Lupin hits 32-month low; stock down 5% in two days  Business Standard3 weeks ago

Structural changes across US, Japan amp; India to impact Lupin this year: Vice-chairman

"There are major structural changes taking place in the pharma business across the globe whether it is US or India or Japan and that will put pressure," said Kamal K. Sharma, vice chairman of Lupin in an exclusive interview to Moneycontrol.
 Money Control7 hours ago
Money Control

When Rakesh Jhunjhunwala grilled Lupin top brass after muted Q4 results

Amid regulatory headwinds from the USFDA and pricing pressure back in India, Jhunjhunwala asked about growing consolidation on the buying side in the industry and can it also extend towards sell side consolidation.
 Money Control9 hours ago
Money Control

Stocks in the news: IOC, Cipla, Max Financial, Lupin, Dish TV, Jain Irrigation

Max Financial | JP Power | Lupin | Dish TV | Jain Irrigation | Ashoka Buildcon | Sarla Performance Fibers and Kalpataru Power Transmission are stocks, which are in news today.
 Money Control13 hours ago Stocks in the news: Max Financial, JP Power, Lupin, Dish TV, Jain Irrigation, Ashoka Buildcon  Money Control13 hours ago

FY18 will be challenging for Lupin: Nilesh Gupta

Interview with Lupin managing director Nilesh Gupta
 Business Standard19 hours ago Lupin gets 6 USFDA observations for Indore plant  Money Control1 day ago Lupin expects muted growth in the US despite new launches  Business Standard1 month ago Our priority is to acquire speciality drugmakers in the US: Nilesh Gupta  Business Standard2 months ago

Lupin's Q4 profit falls 39%; income down at Rs 2,965.71 crore

Pharma major Lupin on Wednesday reported a fall of 39.48 per cent in its standalone net profit after tax (PAT) to Rs 549.05 crore during the fourth quarter (Q4) ended March 31, 2017.The net PAT of the pharma major stood at Rs 907.24 crore during the ...
 Prokerala1 day ago Drugmaker Lupin's profit halves as U.S. sales slump  Business Standard1 day ago Lupin Q4 net profit halves  Sify1 day ago US sales drag Lupin#39;s net profit 49.2% to Rs 380 crore, results miss Street estimates  Money Control1 day ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less